About Us

Spotlight Innovation Inc. (OTCQB: STLT) identifies and acquires rights to innovative and proprietary platform technology candidates with a focus on cancer drugs and treatment therapies, solutions for infectious disease, and other specialty and unique opportunities.

Access to platform technology candidates is accomplished via our extensive relationships with many leading academic institutions and other sources. We provide value added development capability and funding in order to accelerate development progress. When commercially significant benchmarks have been achieved, we will partner with proven market leaders via sale, out-license or strategic alliance.

Learn more About Us

Visit the Investor Relations page

Making a Difference

0
Est. Cancer Diagnoses, US 2016
0
Est. Cancer Deaths, US 2016
0
Est. Cancer Fatalities/Day, US 2016

Spotlight Innovation is dedicated to meaningfully impacting patient health by advancing new platform biotechnologies for cancer and infectious disease.